We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.04B
1-Year Est. Return 49.7%
This Fund
S&P 500
This Quarter Est. Return
+22.34%
1 Year Est. Return
+49.7%
3 Year Est. Return
+155.82%
5 Year Est. Return
+205.73%
10 Year Est. Return
+1,384.8%
AUM
$1.41B
AUM Growth
+$16.5M
Cap. Flow
-$197M
Cap. Flow %
-13.97%
Top 10 Hldgs %
28.49%
Holding
157
New
34
Increased
26
Reduced
48
Closed
23

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$23.3M
2
MRNA icon
Moderna
MRNA
+$22.5M
3
AMGN icon
Amgen
AMGN
+$19.2M
4
MSFT icon
Microsoft
MSFT
+$17.4M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 21.41%
3 Financials 18.15%
4 Consumer Discretionary 14.25%
5 Real Estate 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDD icon
51
Pinduoduo
PDD
$129B
$10.6M 0.75%
59,400
+51,800
+682% +$6.19M
LYFT icon
52
Lyft
LYFT
$6.19B
$10.4M 0.74%
+210,700
New +$7.67M
AVGO icon
53
Broadcom
AVGO
$2T
$10.1M 0.71%
+229,700
New +$8.95M
FIVN icon
54
FIVE9
FIVN
$2.17B
$9.98M 0.71%
57,250
-4,380
-7% -$666K
RNG icon
55
RingCentral
RNG
$5.18B
$9.88M 0.7%
26,070
-890
-3% -$277K
STC icon
56
Stewart Information Services
STC
$2.09B
$9.87M 0.7%
204,100
+2,900
+1% +$132K
RPTX
57
DELISTED
Repare Therapeutics
RPTX
$9.64M 0.69%
280,979
+79,200
+39% +$2.37M
TWLO icon
58
Twilio
TWLO
$29.3B
$9.45M 0.67%
27,925
-1,635
-6% -$511K
VCYT icon
59
Veracyte
VCYT
$3.71B
$9.45M 0.67%
193,160
-30,800
-14% -$1.43M
SE icon
60
Sea Limited
SE
$68B
$9.25M 0.66%
46,480
+45,180
+3,475% +$8.04M
PENG
61
Penguin Solutions Inc
PENG
$2.88B
$9.13M 0.65%
+485,400
New +$7.25M
SDC
62
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$9.05M 0.64%
758,000
+151,600
+25% +$1.72M
GDS icon
63
GDS Holdings
GDS
$6.38B
$8.93M 0.64%
95,395
+87,200
+1,064% +$7.75M
ABBV icon
64
AbbVie
ABBV
$431B
$8.93M 0.63%
83,290
-41,010
-33% -$3.94M
AMGN icon
65
Amgen
AMGN
$219B
$7.34M 0.52%
31,932
-83,185
-72% -$19.2M
ZTS icon
66
Zoetis
ZTS
$32.4B
$6.98M 0.5%
42,175
SPLK
67
DELISTED
Splunk Inc
SPLK
$6.2M 0.44%
36,470
MRNA icon
68
Moderna
MRNA
$21.5B
$5.75M 0.41%
55,062
-222,240
-80% -$22.5M
ASHR icon
69
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$5.25M 0.37%
131,100
DT icon
70
Dynatrace
DT
$14.2B
$4.78M 0.34%
+110,400
New +$4.38M
TDOC icon
71
Teladoc Health
TDOC
$1.21B
$4.7M 0.33%
23,525
-61,689
-72% -$12.5M
FUSN
72
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$4.69M 0.33%
399,399
-3,401
-0.8% -$42.7K
BABA icon
73
Alibaba
BABA
$304B
$4.57M 0.33%
19,647
GOSS icon
74
Gossamer Bio
GOSS
$87.2M
$4.45M 0.32%
459,834
WDAY icon
75
Workday
WDAY
$42B
$4.13M 0.29%
17,250

Similar funds

Clough Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Clough Capital Partners held 157 positions worth $1.41B, up 1.2% from $1.39B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Clough Capital Partners withdrew a net $197M in Q4 2020, closing 23 positions and reducing 48 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $23.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

Against the trend, Clough Capital Partners opened a new position in Micron Technology worth $36.1M.

  • Clough Capital Partners's largest Q4 2020 buy was Micron Technology: 480,700 shares worth $36.1M.
  • Clough Capital Partners added most to TransDigm Group in Q4 2020, an estimated $11.1M increase.
  • Clough Capital Partners's biggest Q4 2020 reduction was Moderna, cutting an estimated $22.5M.
  • Clough Capital Partners fully exited Meta Platforms (Facebook) in Q4 2020, selling an estimated $23.3M.
  • Clough Capital Partners's ten largest holdings make up 28% of its $1.41B portfolio in Q4 2020.
  • Clough Capital Partners opened 34 new positions and closed 23 in Q4 2020.
  • Clough Capital Partners's portfolio value rose 1.2% quarter-over-quarter to $1.41B.

Based on Clough Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.